{"id":"https://genegraph.clinicalgenome.org/r/398137a7-aa49-40aa-b995-9feb0b22c1ddv1.0","type":"EvidenceStrengthAssertion","dc:description":"LRRK2 was first reported in relation to autosomal-dominant Parkinson´s disease in 2004 (Paisan-Ruiz et al., PMID: 15541308; Zimprich et al., PMID: 15541309). Parkinson´s disease is a progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra, and Lewy bodies in the substantia nigra and locus coeruleus are found in most cases. In patients with pathogenic LRRK2 variants, the typical Parkinson´s disease pathology with Lewy bodies can often been found (Ross et al. 2006, PMID: 16437559; Kalia et al. 2015, PMID: 25401511) but tau-immunopositive neurofibrillary tangles have also been reported (Rajput et al. 2006, PMID: 17060589). Signs and symptoms of Parkinson´s disease include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements (bradykinesia), a tendency to fall back (postural instability). Several clearly pathogenic, missense variants have been reported in >1000 probands in >100 publications (for review see Trinh et al. 2018, PMID: 30357936, www.mdsgene.org) of which five publications are included in this curation. The most frequently found mutation is c.6055G>A/p.G2019S (NM_198578, ClinVar ID: 1940). The additional evidence from the literature was not included in this curation because the maximum score for genetic evidence (12 pts.) has been reached. Although the disease follows a clearly dominant mode of inheritance with age-dependent reduced penetrance, homozygous carriers of pathogenic variants have been reported with comparable phenotype to heterozygous carriers (Ishihara et al. 2006, PMID: 16966502). The mechanism of pathogenicity appears to be gain-of-function (GOF) with augmented kinase activity (West et al. 2005, PMID: 16269541). The gain-of-function mechanism is also underlined by the lack of Parkinson´s disease in carriers of truncating variants (Blauwendraat et al. 2018, PMID: 30039155). This gene-disease association is further supported by recurrent experimental evidence including animal models, in-vitro functional assays, and patient-derived cells (Giasson et al. 2006, PMID: 16437584; Jaleel et al. 2007, PMID: 17447891; Luzón-Toro et al. 2007, PMID: 17584768; Liu et al. 2008, PMID: 18258746; Fraser et al. 2016, PMID: 26865512; Boecker et al. 2021, PMID: 33765413). In summary, pathogenic variants in LRRK2 are definitively causing autosomal-dominant Parkinson´s disease. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Parkinson’s Disease Gene Curation Expert Panel on May 3, 2021.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/398137a7-aa49-40aa-b995-9feb0b22c1dd","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10079","date":"2021-05-03T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10079","date":"2021-06-15T00:23:18.153Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be7e5282-894c-4259-8e64-072229b38dc4_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Recurrent variant in multiple families (>15) with available functional evidence from different studies","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e51b50c9-3029-4bcf-824c-8e07c532192e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541309","rdfs:label":"Family 32_1","firstTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/be7e5282-894c-4259-8e64-072229b38dc4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541309","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8e8e362-0a5f-480f-9166-a67a44b8c422","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198578.4(LRRK2):c.6059T>C (p.Ile2020Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339928"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e008c376-54d9-402b-8427-a188d60ea0c3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Multiple families (>100) and multiple functional studies. Best established and most frequent pathogenic variant in LRRK2","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e06adf12-f551-414f-b401-7a6cc15a7879","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15680456","rdfs:label":"LISB-01","detectionMethod":"The 51 exons of LRRK2were  amplified  from  genomic  DNA  using  PCR  anddirectly sequenced in both strands. ","firstTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e008c376-54d9-402b-8427-a188d60ea0c3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15680456","allele":{"id":"https://genegraph.clinicalgenome.org/r/013fd704-8b9e-4383-8fd2-87e2011058a3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198578.4(LRRK2):c.6055G>A (p.Gly2019Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339926"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1e0e2d0b-6ead-4209-bb49-914494b6b012_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Clearly pathogenic variant, Found in multiple multiplex families (>15) with functional evidence in multiple studies","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da83a53e-dfb7-483e-a881-a7abd1dbbe64","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541308","rdfs:label":"PL_1","firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1e0e2d0b-6ead-4209-bb49-914494b6b012_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541308","allele":{"id":"https://genegraph.clinicalgenome.org/r/0516bb99-c433-4c90-87c4-ff6560cfd4dd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198578.4(LRRK2):c.5096A>G (p.Tyr1699Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339920"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/6a82c15f-2ac7-4454-9c2e-13af899aca5c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Clearly pathogenic recurrent variant, found in >20 families, multiple studies with functional evidence","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd76cddd-e55e-427c-a97f-86e6ece0d3c1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541309","rdfs:label":"III-20","firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6a82c15f-2ac7-4454-9c2e-13af899aca5c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541309","allele":{"id":"https://genegraph.clinicalgenome.org/r/0514f118-5185-40e7-8867-033f556c30de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198578.4(LRRK2):c.4321C>T (p.Arg1441Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339922"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4d546d60-e946-4f15-8f3b-d09507f75306_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a43b5f55-e4e3-4802-80a3-96bd4a6d2956","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21686713","rdfs:label":"Case","firstTestingMethod":"Restriction digest","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4d546d60-e946-4f15-8f3b-d09507f75306_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21686713","allele":{"id":"https://genegraph.clinicalgenome.org/r/013fd704-8b9e-4383-8fd2-87e2011058a3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/68b16ee9-867f-4377-833b-92d2e7bda44f_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0126343a-9ae2-4cb7-8eef-20e4d91c9949","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31422003","rdfs:label":"1906-1767","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":50,"detectionMethod":"TaqMan SNP Genotyping Assays (Life Technologies Europe) and positive samples confirmed by Sanger sequencing","firstTestingMethod":"Genotyping","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/68b16ee9-867f-4377-833b-92d2e7bda44f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31422003","allele":{"id":"https://genegraph.clinicalgenome.org/r/013fd704-8b9e-4383-8fd2-87e2011058a3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b6fbd4f6-60b8-4ce0-95ba-e77540204a06_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d997485b-9b75-45ee-a84e-0afdb1caa4e1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31422003","rdfs:label":"1906-1119","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":53,"detectionMethod":"TaqMan SNP Genotyping Assays (Life Technologies Europe) and confirmation of positive samples by Sanger sequencing","firstTestingMethod":"Genotyping","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b6fbd4f6-60b8-4ce0-95ba-e77540204a06_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31422003","allele":{"id":"https://genegraph.clinicalgenome.org/r/013fd704-8b9e-4383-8fd2-87e2011058a3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b42000bc-2f1a-481a-8b08-27e6ea5b22db_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Recurrent mutation in multiple families (>20) with functional evidence in multiple studies; well establish pathogenic variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48f0c4fd-00e0-44e8-913f-0bf9d82b08e1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541308","rdfs:label":"UGM003_1","firstTestingMethod":"Linkage analysis","previousTesting":true,"previousTestingDescription":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/b42000bc-2f1a-481a-8b08-27e6ea5b22db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541308","allele":{"id":"https://genegraph.clinicalgenome.org/r/c34550a2-f5ae-4846-9526-9f02347de9c0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198578.4(LRRK2):c.4321C>G (p.Arg1441Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339918"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":7},{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5812c11-5087-4d5c-9106-b0cfdb73ca7d_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541308","rdfs:label":"UGM005","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/c5812c11-5087-4d5c-9106-b0cfdb73ca7d","type":"Family","rdfs:label":"UGM005"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/d5da1343-04cc-4b14-9cab-cf6e505df376_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541309","rdfs:label":"Family 32","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/d5da1343-04cc-4b14-9cab-cf6e505df376","type":"Family","rdfs:label":"Family 32","member":{"id":"https://genegraph.clinicalgenome.org/r/e51b50c9-3029-4bcf-824c-8e07c532192e"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e51b50c9-3029-4bcf-824c-8e07c532192e"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/546910a2-cf18-4b04-91e5-4ebe9ed96ad8_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541309","rdfs:label":"Family A","family":{"id":"https://genegraph.clinicalgenome.org/r/546910a2-cf18-4b04-91e5-4ebe9ed96ad8","type":"Family","rdfs:label":"Family A"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":8,"publishedLodScore":3.78,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/2813d4f9-5dcc-4503-92dc-93804a6b8085_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541308","rdfs:label":"UGM003","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/2813d4f9-5dcc-4503-92dc-93804a6b8085","type":"Family","rdfs:label":"UGM003","member":{"id":"https://genegraph.clinicalgenome.org/r/48f0c4fd-00e0-44e8-913f-0bf9d82b08e1"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/48f0c4fd-00e0-44e8-913f-0bf9d82b08e1"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/071f9c97-edb9-4407-addd-2c2cb3a58c96_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15680456","rdfs:label":"LISB","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/071f9c97-edb9-4407-addd-2c2cb3a58c96","type":"Family","rdfs:label":"LISB","member":{"id":"https://genegraph.clinicalgenome.org/r/e06adf12-f551-414f-b401-7a6cc15a7879"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e06adf12-f551-414f-b401-7a6cc15a7879"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/56769fb1-1e79-438f-9550-449c345c16c0_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541308","rdfs:label":"UGM006","estimatedLodScore":2.71,"family":{"id":"https://genegraph.clinicalgenome.org/r/56769fb1-1e79-438f-9550-449c345c16c0","type":"Family","rdfs:label":"UGM006"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/91ccfa4f-21d1-43a4-92ad-1997c25b5ac8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541309","rdfs:label":"Family D","estimatedLodScore":4.82,"family":{"id":"https://genegraph.clinicalgenome.org/r/91ccfa4f-21d1-43a4-92ad-1997c25b5ac8","type":"Family","rdfs:label":"Family D","member":{"id":"https://genegraph.clinicalgenome.org/r/dd76cddd-e55e-427c-a97f-86e6ece0d3c1"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":10,"proband":{"id":"https://genegraph.clinicalgenome.org/r/dd76cddd-e55e-427c-a97f-86e6ece0d3c1"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/77b72697-4b38-4b49-b113-849c66a5c78d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541308","rdfs:label":"PL","estimatedLodScore":2.71,"family":{"id":"https://genegraph.clinicalgenome.org/r/77b72697-4b38-4b49-b113-849c66a5c78d","type":"Family","rdfs:label":"PL","member":{"id":"https://genegraph.clinicalgenome.org/r/da83a53e-dfb7-483e-a881-a7abd1dbbe64"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/da83a53e-dfb7-483e-a881-a7abd1dbbe64"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/7a409ed7-4000-4781-8f19-02bb9f6b29af_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15541308","rdfs:label":"UGM004","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/7a409ed7-4000-4781-8f19-02bb9f6b29af","type":"Family","rdfs:label":"UGM004"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03f2e782-8ab8-4a0a-8692-a95ae27b88f8","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03f2e782-8ab8-4a0a-8692-a95ae27b88f8_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16250030","rdfs:label":"U.S. Movement Disorder Clinics","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/c2c47358-6611-4064-867a-093ec68b7532","type":"Cohort","allGenotypedSequenced":1425,"alleleFrequency":0.01263157894736842,"detectionMethod":"The 6055 G to A transition (which encodes G2019S) was detected using a TaqMan SNP assay on an ABI Prism 7900HT sequence detection system (Applied Biosystems, Foster City, CA). All mutations detected by the TaqMan assay were subsequently veriﬁed by sequencing. ","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03f2e782-8ab8-4a0a-8692-a95ae27b88f8_cc_evidence_item"}],"numWithVariant":18,"relatedCondition":{"id":"obo:MONDO_0005180"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/63483348-2b78-40bb-b475-ae2aba138a28","type":"Cohort","allGenotypedSequenced":1647,"alleleFrequency":0.0006071645415907711,"detectionMethod":"The 6055 G to A transition (which encodes G2019S) was detected using a TaqMan SNP assay on an ABI Prism 7900HT sequence detection system (Applied Biosystems, Foster City, CA). All mutations detected by the TaqMan assay were subsequently veriﬁed by sequencing. ","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03f2e782-8ab8-4a0a-8692-a95ae27b88f8_cc_evidence_item"}],"numWithVariant":1},"method":{"id":"cg:SingleVariantAnalysis"},"pValue":0.00010,"statisticalSignificanceType":"Fisher´s exact","statisticalSignificanceValueType":"Other"}],"specifiedBy":"GeneValidityCaseControlSingleVariantAnalysisCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6731a20-396e-4e4c-83d4-4c6f4a235af1","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0045337-19a2-4b64-9ba6-eabb6bb09b6e","type":"Finding","dc:description":"In this paper, the authors show the same functional alterations in human IPSC-derived neurons and neurons from the knockin mouse model","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33765413","rdfs:label":"autophagic vesicle transport (G2019S knockin mouse neurons)","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/87fe4d0e-7e7d-42aa-8244-c7ac96c07e00","type":"EvidenceLine","dc:description":"Highly convincing model with evidence on different levels (clinical phenotype, pathological phenotype, treatment response)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cda5f1e2-daa2-4f2b-87d3-5c86e94101e8","type":"Finding","dc:description":"The fly model recapitulates the findings in humans in terms of clinical phenotype, selective cell loss, and response to treatment with L-Dopa.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18258746","rdfs:label":"Expression of LRRK2-G2019S in neurons of Drosophila","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0db2cb7f-6026-4458-b392-e7dc39e6733d","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/557db4f5-8b19-428a-ba18-41ffb332912a","type":"FunctionalAlteration","dc:description":"High (AUC=1 for LRRK2 mutations carriers vs. non-carriers)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26865512","rdfs:label":"LRRK2 autophosphorylation in urine exosomes"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/149f2875-b944-4d29-835b-991f518b2562","type":"EvidenceLine","dc:description":"Results could not be confirmed by the authors for this variant in a follow-up study (https://www.medrxiv.org/content/10.1101/2021.01.28.21249614v1)","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e5cfbda-9a90-44e0-888a-67fec45700a0","type":"FunctionalAlteration","dc:description":"increased phosphorylation with high evidence. multiple studies have shown this effect including West et al. 2005","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29127255","rdfs:label":"quantify LRRK2 kinase pathway activity by measuring LRRK2-me"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a4fa4649-9b6a-47a9-8845-64bf39260e76","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa44a2d2-460c-4948-8122-49ff7886c2a6","type":"FunctionalAlteration","dc:description":"high (reduced the processivity of autophagosome transport)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33765413","rdfs:label":"human induced pluripotent stem cell (iPSC)-derived neurons"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2728e13a-b95a-4c55-8cba-082260094ecd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0a94898-ce6e-4acb-a941-6b472926137d","type":"EvidenceLine","dc:description":"Repeatedly shown that there is increased phosphorylation due to several LRRK2 variants, especially for p.G2019S","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18bc93a1-beb7-42f2-bf15-82c6399ca69d","type":"Finding","dc:description":"Increased phosphorylation of LRRK2 and other target due to increased kinase activity","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16269541","rdfs:label":"in vitro kinase assays","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":2933,"specifiedBy":"GeneValidityCriteria8","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/QMJjLUlB1Qs","type":"GeneValidityProposition","disease":"obo:MONDO_0005180","gene":"hgnc:18618","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2728e13a-b95a-4c55-8cba-082260094ecd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}